{
    "2019-05-16": [
        [
            {
                "time": "2018-01-02",
                "original_text": "XLV, JNJ, UNH, PFE: Large Inflows Detected at ETF",
                "features": {
                    "keywords": [
                        "Large Inflows",
                        "ETF"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Pfizer's Eczema Candidate Meets All Goals in Phase III Study",
                "features": {
                    "keywords": [
                        "Eczema",
                        "Phase III",
                        "Goals"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Pfizer Gains After Being Named 'Top Pick' by Credit Suisse",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Top Pick",
                        "Credit Suisse"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Here are the biggest analyst calls of the day: Macy's, Pfizer, Owens Corning & more",
                "features": {
                    "keywords": [
                        "analyst calls",
                        "Macy's",
                        "Pfizer",
                        "Owens Corning"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "retail",
                        "pharmaceuticals",
                        "industrials"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Stocks making the biggest moves premarket: Walmart, Pfizer, PG&E, Sony, Tesla & more",
                "features": {
                    "keywords": [
                        "premarket",
                        "Walmart",
                        "Pfizer",
                        "PG&E",
                        "Sony",
                        "Tesla"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "retail",
                        "pharmaceuticals",
                        "utilities",
                        "technology",
                        "automobiles"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Generic Drugs Are Stabilizing â€” Can They Survive An Antitrust Scandal?",
                "features": {
                    "keywords": [
                        "Generic Drugs",
                        "Stabilizing",
                        "Antitrust Scandal"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}